Summary
Visterra, Inc. (Visterra), formerly Parasol Therapeutics, Inc., is a biotechnology company that offers treatment. It undertakes the discovery and development of pharmaceutical products for the treatment of infectious diseases. The company utilizing proprietary Hierotope Platform deals with infections in organism that are polymorphic and undergoes frequent mutations. Visterra’s technology uses the Atomic Interaction Network analysis technique to identify and define amino acid clusters in a protein. The company’s product VIS410, is used in the treatment of influenza, and has many other products under development for the treatment of complex viral diseases such as HIV, influenza, and dengue fever. Visterra is headquartered in Cambridge, Massachusetts, the US.
Visterra, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
                     
                                   '
                        
Table of Contents
Table of Contents  2
List of Tables  3
List of Figures  4
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Visterra, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
Visterra, Inc., Medical Devices Deals, 2010 to YTD 2016  9
Visterra, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
Visterra, Inc., Pharmaceuticals & Healthcare, Deal Details  12
Venture Financing  12
Visterra Raises USD30 Million in Series B Venture Financing  12
Visterra Raises US$8.1 Million In Extended Series A Financing  14
Visterra Raises Additional US$13 Million In Series A Financing  16
Visterra Secures US$6 Million In First Round Of Financing  18
Partnerships  19
Visterra Enters into Co-Development Agreement with Agency for Science, Technology and Research  19
Visterra Enters Into Agreement With Pfizer To Discover Novel Antibodies  20
Visterra Forms Joint Venture With SMART Centre And National Research Foundation  21
Licensing Agreements  22
Serum Institute of India Enters into Licensing Agreement with Visterra  22
Visterra Enters Into Licensing Agreement With MIT For Dengue Virus Antibodies  24
Equity Offering  26
Visterra Files Registration Statement for IPO for up to USD69 Million  26
Visterra, Inc. - Key Competitors  28
Key Employees  29
Locations And Subsidiaries  30
Head Office  30
Appendix  31
Methodology  31
About GlobalData  31
Contact Us  31
Disclaimer  31
List of Tables
Visterra, Inc., Pharmaceuticals & Healthcare, Key Facts  1
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Visterra, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016  6
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Visterra, Inc., Deals By Therapy Area, 2010 to YTD 2016  8
Visterra, Inc., Medical Devices Deals, 2010 to YTD 2016  9
Visterra, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016  10
Visterra Raises USD30 Million in Series B Venture Financing  12
Visterra Raises US$8.1 Million In Extended Series A Financing  14
Visterra Raises Additional US$13 Million In Series A Financing  16
Visterra Secures US$6 Million In First Round Of Financing  18
Visterra Enters into Co-Development Agreement with Agency for Science, Technology and Research  19
Visterra Enters Into Agreement With Pfizer To Discover Novel Antibodies  20
Visterra Forms Joint Venture With SMART Centre And National Research Foundation  21
Serum Institute of India Enters into Licensing Agreement with Visterra  22
Visterra Enters Into Licensing Agreement With MIT For Dengue Virus Antibodies  24
Visterra Files Registration Statement for IPO for up to USD69 Million  26
Visterra, Inc., Key Competitors  28
Visterra, Inc., Key Employees  29
List of Figures
Visterra, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  1
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  1
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  1
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  1
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016  5
Visterra, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016  6
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016  7
Visterra, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016  8
Visterra, Inc., Medical Devices Deals, 2010 to YTD 2016  9